News

Filter

Current filters:

Hematology

1 to 9 of 126 results

Positive Ph III results from Biogen Idec and SOBI’s Alprolix in pediatric study

Positive Ph III results from Biogen Idec and SOBI’s Alprolix in pediatric study

28-02-2015

US biotech major Biogen Idec and Nordic drugmaker Swedish Orphan Biovitrum have announced positive top-line…

AlprolixBiogen IdecBiotechnologyEuropeHematologyRegulationResearchSobiSwedish Orphan Biovitrum

Intas becomes first Indian company to launch biosimilar in the EU

Intas becomes first Indian company to launch biosimilar in the EU

23-02-2015

Indian biopharma company Intas has become the first Indian company to launch a biosimilar in highly regulated…

BiosimilarsBiotechnologyFilgrastimHematologyImmunologicalsIndiaIntas PharmaceuticalsMarkets & MarketingRegulation

Pluristem trial with NIH gives positive results for PLX-R18 on bone marrow radiation damage

Pluristem trial with NIH gives positive results for PLX-R18 on bone marrow radiation damage

20-02-2015

Israeli cell therapy specialist Pluristem Therapeutics has announced the positive results of a recent…

BiotechnologyHematologyIsraelPluristem TherapeuticsPLX cellsResearch

IQWiG says Octapharma provided no suitable data on Nuwiq to show added benefit

IQWiG says Octapharma provided no suitable data on Nuwiq to show added benefit

20-02-2015

The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined data on independent…

BiotechnologyGermanyHematologyNuwiqOctapharmaPricingRegulation

CSL delivers solid first-half financials, but guidance disappoints

11-02-2015

Australian plasma fractionation specialist CSL Limited has today announced a net profit after tax (NPAT)…

BiotechnologyCSL LimitedFinancialHematologyVaccines

Novartis' Japan unit faces 15-day suspension over trial data manipulation

Novartis' Japan unit faces 15-day suspension over trial data manipulation

04-02-2015

The Japanese unit of Swiss drug major Novartis is facing suspension following allegations of data manipulation…

DiovanHematologyJapanLegalNovartis PharmaceuticalsOncologyPharmaceuticalRegulation

FDA expands approval of Johnson & Johnson/Pharmacyclics' Imbruvica to Waldenstrom’s macroglobulinemia

FDA expands approval of Johnson & Johnson/Pharmacyclics' Imbruvica to Waldenstrom’s macroglobulinemia

30-01-2015

The US Food and Drug Administration has expanded approval of Johnson & Johnson and Pharmacyclics’ Imbruvica…

HematologyImbruvicaJohnson & JohnsonPharmaceuticalPharmacyclicsRegulationUSA

Phase III trial shows Novartis' Jakavi significantly improves hematocrit control

Phase III trial shows Novartis' Jakavi significantly improves hematocrit control

29-01-2015

Results from the pivotal Phase III trial of Jakavi (ruxolitinib) carried out by Swiss drug major Novartis…

HematologyJakaviNovartisPharmaceuticalResearch

1 to 9 of 126 results

COMPANY SPOTLIGHT

Menarini

Back to top